Human Molecular GeneticsNeurosciencePeer-reviewed journal article
Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 Synthase Deficiency variants
Michelle DookwahiD, Shannon K. Wagner, Mayumi Ishihara, Seok‐Ho YuiD, Heidi Ulrichs, Michael J. KulikiD, Nadja ZeltneriD, Stephen DaltoniD, Kevin A. StraussiD, Kazuhiro AokiiD, Richard SteetiD, Michael TiemeyeriD
Abstract
GM3 Synthase Deficiency (GM3SD) is a neurodevelopmental disorder resulting from pathogenic variants in the ST3GAL5 gene, which encodes GM3 synthase, a glycosphingolipid (GSL)-specific sialyltransferase. This enzyme adds a single 3-linked sialic acid to the terminal galactose of lactosylceramide (LacCer) to produce the monosialylated ganglioside GM3. In turn, GM3 is extended by other glycosyltransferases to generate nearly all the complex gangliosides enriched in neural tissue. Pathogenic mechanisms that account for neural phenotypes associated with GM3SD are not known. To explore how loss of GM3 impacts neural-specific glycolipid glycosylation and cell signaling, GM3SD patient fibroblasts bearing one of two different ST3GAL5 variants were reprogrammed to induced pluripotent stem cells (iPSCs) and then differentiated to neural crest cells (NCCs). GM3 and GM3-derived gangliosides were undetectable in iPSCs and NCCs from both variants, while LacCer precursor levels were elevated compared to wildtype (WT). NCCs of both variants synthesized elevated levels of neutral lacto- and globo-series, as well as minor alternatively sialylated, GSLs compared to WT. Shifts in ceramide profiles associated with iPSC and NCC GSLs were also detected in GM3SD variants. Altered GSL profiles in the GM3SD cells were accompanied by dynamic changes in the cell surface proteome, protein O-GlcNAcylation, and receptor tyrosine kinase abundance. GM3SD cells also exhibited increased apoptosis and sensitivity to erlotnib, an inhibitor of epidermal growth factor receptor signaling. Pharmacologic inhibition of O-GlcNAcase increased protein O-GlcNAcylation and significantly rescued baseline and erlotnib-induced apoptosis. Collectively, these findings indicate broad effects on cell signaling during differentiation of GM3SD patient-derived iPSCs to NCCs. Thus, human GM3SD cells provide a novel platform to investigate structure/function relationships that connect GSL diversity to cell signaling, cell survival, and neural differentiation.
- Citations
- 12
- FWCI
- 2.12
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sialylated Gangliosides are Required for Plasma Membrane Organization and Neuronal Function
Henry G. Barrow, Zhuang Zhuang Han, … Janet Elwyn Deane·bioRxiv·Apr 16, 2026
- Gangliosides in neural stem cell fate determination and nerve cell specification--preparation and administration
Yutaka Itokazu, Toshio Ariga, … Dongpei Li·Methods in molecular biologyPeer-reviewed·Jan 1, 2026
- Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes
Elisabeth Mangiameli, Anna Cecchele, … Angela Gritti·Stem Cell ReportsPeer-reviewed·May 13, 2021
- GD3 synthase deficiency disrupts Na+/K+-ATPase and plasma membrane Ca2+-ATPase function in mouse brain
Borna Puljko, Nikolina Maček Hrvat, … Kristina Mlinac·Neurobiology of DiseasePeer-reviewed·May 15, 2026
- Ganglioside GD3 regulates neural stem cell quiescence and controls postnatal neurogenesis
Takahiro Fuchigami, Yutaka Itokazu, Robert K. Yu·GliaPeer-reviewed·Sep 5, 2023
- Plasma Membrane Remodelling in GM2 Gangliosidoses Drives Synaptic Dysfunction
Alex S. Nicholson, David A. Priestman, … Janet Elwyn Deane·bioRxiv·Aug 20, 2024